Partner Therapeutics Announces Publication of Results From the eNRGy Trial of Zenocutuzumab in Patients with NRG1+ Cholangiocarcinoma in Journal of Clinical Oncology (JCO)

Partner Therapeutics announced publication of the eNRGy trial results of Zenocutuzumab in NRG1+ cholangiocarcinoma, highlighting potential treatment implications.

Ankündigung Tenderverfahren – Neue 10-jährige Anleihe des Bundes

Der Bund plant eine neue 10-jährige Bundesanleihe, das Tenderverfahren wurde offiziell angekündigt. Details zu Zeitplan und Konditionen folgen.

RHEO: Paint With Light

RHEO is a forthcoming light-painting app for iPhone, iPad and Apple Vision Pro, according to Thorsten Meyer AI.

RHEO: Paint With Light

Thorsten Meyer AI detailed RHEO, a forthcoming light-painting app for iPhone, iPad and Apple Vision Pro.

When One Agent Isn’t Enough: Claude Now Builds Its Own Team of Agents on the Fly

Anthropic says Claude Code can generate task-specific workflows that spawn subagents, raising gains and cost questions for complex AI work.

11 Best Investment-Themed Patriotic Accessories in 2026

Discover the top investment-themed patriotic accessories for 2026. From commemorative coins to jewelry, find the best options for your patriotic investment needs.

When One Agent Isn’t Enough: Claude Now Builds Its Own Team of Agents on the Fly

Anthropic says Claude Code can now create task-specific workflows that spawn and coordinate subagents for complex work.

The Real Cost of a Local-Inference Rig in 2026

A Thorsten Meyer AI report says VRAM capacity, not the newest GPU, is the main cost driver for local AI inference rigs in 2026.

The Real Cost of a Local-Inference Rig in 2026

Thorsten Meyer AI says local inference rigs in 2026 should be priced around VRAM needs, not the newest GPU.

Software-Defined Warfare: How Ukraine’s Delta Turned the Battlefield Into a Shared, Real-Time Map

A July 1 briefing frames Ukraine’s Delta as battlefield software, while target counts, cyber risk and wartime effects remain unclear.